Skip to main content
Trusted advisor to healthcare practitioners · Est. 2016
Blog · Regenerative Medicine Doctors

PRP vs. Exosomes vs. MSCs in 2026: How to Actually Choose

A practical, indication-by-indication decision framework for regenerative physicians choosing between PRP, exosomes, MSCs, and amniotic tissue in 2026.

Published February 20, 2026 · 6 min read · Back to Regenerative Medicine Doctors

Match the biologic to the tissue

PRP still wins for early tendinopathy, hair restoration, and aesthetic priming. Exosomes outperform PRP for skin, sexual wellness, and hair when patients want faster visible response. MSCs and amniotic tissue are the choice for advanced joint disease and complex wounds.

2026 protocol combinations that are working

Knee OA (KL 2–3): amniotic + ECSWT + BPC-157 support. Rotator cuff partial tear: leukocyte-poor PRP + HPLT + collagen peptides. Hair: exosomes + PRP boosters + LLLT cap at home. ED: exosomes + focused shockwave + sildenafil/tadalafil taper.

Sourcing and compliance

Work only with cGMP suppliers with clear COAs. For cellular and amniotic products, confirm the HCT/P pathway. We supply the full 2026 stack — see /biologics and /devices for the current portfolio.

Ready to add these services to your practice?

We supply biologics, devices, and peptide protocols for Regenerative Medicine Doctors.

Request Consultation →